Supplemental Material, 812058_web_appendix - Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016

Alexander, G. Caleb; Ogasawara, Ken; Wiegand, Dana; Lin, Dora; Breder, Christopher D.

doi:10.25384/SAGE.7441256.v2

812058_web_appendix.pdf (53.42 kB)

Supplemental Material, 812058_web_appendix - Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016

Version 2 2019-11-26, 13:08

Version 1 2018-12-09, 12:01

journal contribution

posted on 2019-11-26, 13:08 authored by G. Caleb Alexander, Ken Ogasawara, Dana Wiegand, Dora Lin, Christopher D. Breder

Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 by G. Caleb Alexander, Ken Ogasawara, Dana Wiegand, Dora Lin, and Christopher D. Breder in Therapeutic Innovation & Regulatory Science